Home > Boards > US OTC > Medical - Drugs > Revive Therapeutics Ltd (RVVTF)

THESE ARE SOME OF THE TOP COMPANIES RACING

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
powerbattles Member Profile
Member Level 
Followed By 2,149
Posts 86,811
Boards Moderated 9
Alias Born 09/12/03
160x600 placeholder
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trialfor Bucillamine in COVID-19 InvestorsHub NewsWire - 7/15/2021 2:47:32 PM
Revive Therapeutics provides update on late-stage bucillamine COVID-19 trial Seeking Alpha - 7/15/2021 1:44:58 PM
Revive Therapeutics Approved to Trade on the OTCQB Market InvestorsHub NewsWire - 6/28/2021 8:00:00 AM
Revive Therapeutics gets approval to trade on OTCQB Market Seeking Alpha - 6/25/2021 3:56:50 PM
Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelics InvestorsHub NewsWire - 6/17/2021 8:59:57 AM
Revive Therapeutics Partners with Supriya to Pursue EUA for Bucillamine to Treat COVID in India InvestorsHub NewsWire - 6/8/2021 9:12:52 AM
Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop Oral Psilocybin Thin Film Strip InvestorsHub NewsWire - 5/17/2021 9:48:35 AM
Revive Therapeutics inks feasibility agreement with LTS Lohmann Seeking Alpha - 5/17/2021 9:30:38 AM
Revive Therapeutics Enters Into Research Agreement with UCSF For Bucillamine As Potential Treatment For Severe COVID-19 InvestorsHub NewsWire - 5/3/2021 9:32:33 AM
Revive inks research agreement to explore use of Bucillamine in treating severe COVID-19 Seeking Alpha - 5/3/2021 9:27:48 AM
Revive Therapeutics Files For FDA Orphan Drug Designation for Psilocybin in Traumatic Brain Injury InvestorsHub NewsWire - 4/27/2021 9:51:20 AM
Revive files for FDA orphan drug status for psilocybin in traumatic brain injury Seeking Alpha - 4/27/2021 9:33:08 AM
Revive Therapeutics Announces Successful Research Results for Oral Thin Film Psilocybin and Filing of U.S. Provisional ....cont InvestorsHub NewsWire - 4/22/2021 8:26:06 AM
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 InvestorsHub NewsWire - 3/24/2021 9:15:00 AM
Revive Therapeutics provides update on late-stage Bucillamine study in COVID-19 Seeking Alpha - 3/24/2021 9:08:15 AM
Revive Therapeutics Announces Successful Research Results for Psilocybin to Treat Traumatic Brain Injury and Filing of ...Cont InvestorsHub NewsWire - 3/19/2021 7:56:39 AM
Revive Therapeutics posts positive data from pre-clinical psilocybin brain injury study Seeking Alpha - 3/19/2021 7:37:00 AM
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion...Cont InvestorsHub NewsWire - 2/26/2021 9:01:27 AM
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion...Cont InvestorsHub NewsWire - 2/26/2021 9:01:27 AM
Revive Therapeutics Acquires Unique Psilocybin Assets InvestorsHub NewsWire - 2/17/2021 9:53:14 AM
Revive Therapeutics acquires psilocybin assets for C$10M Seeking Alpha - 2/17/2021 9:38:20 AM
Revive Therapeutics Provides Update on Cannabinoid Pharmaceuticals Program InvestorsHub NewsWire - 2/11/2021 8:05:24 AM
Revive Therapeutics in Phase 3 clinical trial for COVID-19 treatment InvestorsHub NewsWire - 1/27/2021 8:13:52 AM
How Combat Sports Are Researching Micro-Dosing Psychedelics To Treat Brain Injuries InvestorsHub NewsWire - 1/18/2021 9:51:54 AM
Revive Therapeutics Announces Research Collaboration with North Carolina State University InvestorsHub NewsWire - 1/14/2021 8:30:27 AM
powerbattles Member Level  Friday, 07/31/20 05:54:30 PM
Re: None
Post # of 27693 
THESE ARE SOME OF THE TOP COMPANIES RACING TO PRODUCE PANDEMIC TREATMENTS.


These are Some of the Top Companies Racing to Produce Pandemic Treatments

INO, C.RVV, MRNA | 5 hours ago
The global spread of the pandemic has been stunning. To date, 16.7 million people have been infected around the world. More than 660,000 people have now died. In the U.S. alone, we’ve now seen 4.3 million cases. Brazil is up to 2.4 million cases. India is up to 1.5 million cases. Russia is up to 827,455 cases. South Africa is up to nearly 460,000. Meanwhile, the World Health Organization has warned the situation could get far worse. However, the world may be nearing a vaccine, as many companies enter late-stage trial studies. So far, Moderna and Pfizer have reportedly launched two 30,000-subject trials of vaccines that could lead to regulatory approval and use later this year, according to Reuters. AstraZeneca is another one that said it will begin large scale trials in the U.S. this summer. Some of the top companies to keep an eye on include Revive Therapeutics (CSE:RVV)(OTC:RVVTF),Johnson & Johnson (NYSE:JNJ), Moderna Inc. (NASDAQ:MRNA), Eastman Kodak Company (NYSE:KODK), and Inovio Pharmaceuticals Inc. (NASDAQ:INO).

https://stockhouse.com/news/press-releases/2020/07/31/these-are-some-of-the-top-companies-racing-to-produce-pandemic-treatments


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences